Pure Global

Drug-coated Coronary Artery Stent (Novolimus) - Vietnam Registration 2403500ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Drug-coated Coronary Artery Stent (Novolimus) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại D medical device is registered under number 2403500ĐKLH/BYT-HTTB and manufactured by Elixir Medical Corporation. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN ĐẦU TƯ PHÁT TRIỂN TMT VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2403500ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2403500ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Drug-coated Coronary Artery Stent (Novolimus)
VN: Khung giá đỡ mạch vành phủ thuốc Novolimus
Risk Class TBYT Loại D

Registration Details

2403500ĐKLH/BYT-HTTB

000.00.04.G18-231229-0011

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Elixir Medical Corporation

Technical Details

The drug-eluting coronary stent with Novolimus is a permanently implanted device that combines the drug, Novolimus, and aims to improve the coronary artery diameter in patients with symptomatic coronary artery disease.

Dates and Status

Nov 14, 2024